We are Sorry, This Page doesn't Exist

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) lost a sell-side bull Tuesday, with a B. Riley FBR analyst praising the company's pipeline but concluding the biotech's positives are priced into the stock. Late.....»»

Spotify Technology SA (NYSE: SPOT)'s status as a best-in-class streaming music provider with a superior user experience is one of many reasons why investors can expect the stock to continue to gain value, according to Barclays. Latest Ratin.....»»

Cara Therapeutics shares made a solid gain on Wednesday after the biotech announced positive results from a midstage trial......»»

Biotech stocks had a fairly decent run in June, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) advancing about 3.5 percent through June 22 compared to the S&P 500's 1.8-percent gain. read more.....»»

The market isn't fully appreciating just how much more room this biotech has to grow......»»

Musk says he might take Tesla private. Here are a few things he'd gain by doing so......»»

Lincoln Electric (LECO) is poised to benefit from improvement in end-sector demand and ongoing strategic initiatives despite higher material costs. Lincoln Electric Holdings, Inc. LECO will gain from .....»»

This biotech could deliver big returns for investors who aren't afraid of taking on considerable risk......»»

All kind of people/ShutterstockWhile winter gets a bad rep for weight gain — from sugar cookies to cranberry sauce to all of the hearty casseroles that inexplicably taste better when there’s a chill to the air — summer can also wreak h.....»»

U.S. stock-index futures trade little changed Wednesday, suggesting investors are finding few reasons to push shares decisively higher following a multiday advance that has taken indexes to repeated records......»»

Even after an impressive 32-percent year-to-date gain, a major Wall Street firm came out bullish on Apple, Inc. (NASDAQ: AAPL) Thursday and said there are simply too many positive catalysts for the stock to ignore. Latest Ratings for A.....»»

Investors will need to hold their nerve. RECENT REGULATORY changes in China have led to an outpouring of enthusiasm from investors and biopharmaceutical companies looking to gain a foothold in one of the world's major m.....»»

One big drugmaker's pain was this biotech's gain last month......»»

CBRE Group (CBRE) will gain from improving occupier outsourcing business, leasing, strategic acquisitions and a healthy .....»»

Ultimate Software (ULTI) to gain from robust adoption of its HCM solutions and synergies from PeopleDoc. .....»»

3 Reasons Biotech Should Rally In 2019.....»»

CONSOL Coal Resources (CCR) continues to gain traction from.....»»

Big drugmakers have good reasons for pursuing deals, even if the rest of the M&A market cools......»»

Biotech companies' reasons differ for 600 job cuts over the past few months, but the numbers are jarring for an industry at the intersection of a strong cash position and groundbreaking science......»»

It's another disappointing day for one of America's top biotech companies. But that may prove to be great news for Intercept Pharmaceuticals......»»